Back to Search Start Over

23 - First-in-human phase I trial of the anti-CEACAM5 antibody–drug conjugate SAR408701 in patients with advanced solid tumors (NCT02187848).

Authors :
Gazzah, A.
Stjepanovic, N.
Ryu, M.H.
Tabernero, J.
Soria, J.C.
Bedard, P.
Kang, Y.K.
Bahleda, R.
Guillemin-Paveau, H.
Henry, C.
Hatteville, L.
Zilocchi, C.
Demers, B.
Hierro, C.
Source :
European Journal of Cancer. Dec2016 Supplement 1, Vol. 69, pS14-S15. 1p.
Publication Year :
2016

Details

Language :
English
ISSN :
09598049
Volume :
69
Database :
Academic Search Index
Journal :
European Journal of Cancer
Publication Type :
Academic Journal
Accession number :
120140914
Full Text :
https://doi.org/10.1016/S0959-8049(16)32630-2
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details